LBLTF (Lattice Biologics) Common Stock: $11.01 Mil (As of Jun. 2021)


What is Lattice Biologics Common Stock?

Lattice Biologics LBLTF -99.00% Common Stock is $11.01 Mil as of Jun. 2021.

Lattice Biologics's quarterly common stock stayed the same from Dec. 2020 ($11.01 Mil) to Mar. 2021 ($11.01 Mil) and stayed the same from Mar. 2021 ($11.01 Mil) to Jun. 2021 ($11.01 Mil).

Lattice Biologics's annual common stock stayed the same from Sep. 2018 ($9.62 Mil) to Sep. 2019 ($9.62 Mil) but then increased from Sep. 2019 ($9.62 Mil) to Sep. 2020 ($11.01 Mil).

Lattice Biologics Common Stock Historical Data

* Premium members only.

The historical data trend for Lattice Biologics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lattice Biologics Common Stock Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 9.60 9.62 9.62 11.01

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.35 11.01 11.01 11.01 11.01

Lattice Biologics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $11.01 Mil mean?
Lattice Biologics (LBLTF) has a Common Stock of $11.01 Mil as of Jun. 2021. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Lattice Biologics and its competitors.
Is Lattice Biologics' Common Stock too high?
Lattice Biologics' current Common Stock is $11.01 Mil.
How does Lattice Biologics' Common Stock compare to ABT and MDT?
Lattice Biologics' Common Stock of $11.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Lattice Biologics and its competitors. Lattice Biologics's current Common Stock is $11.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lattice Biologics stock overvalued right now?
Lattice Biologics (LBLTF) has a current Common Stock of $11.01 Mil. The current Common Stock is $11.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Lattice Biologics (LBLTF), the current Common Stock is $11.01 Mil as of Jun. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lattice Biologics Business Description

Address 512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The company's products include ADM dermis, DBM Putty, Bone scaffold, and others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.